BD MAX 耐多药结核检测MTB及异烟肼、利福平耐药突变的多中心准确性研究
该多中心前瞻性研究在南非、乌干达、印度和秘鲁纳入1053例疑似肺结核门诊成人,评估BD MAX MDR-TB检测MTB及利福平、异烟肼耐药的准确性。BD MAX检测MTB敏感性93%、特异性97%;对利福平耐药敏感性90%、特异性95%;对异烟肼耐药敏感性82%、特异性100%。BD MAX可能成为全球快速检测结核及耐多药结核的重要工具。
要点
- BD MAX检测MTB敏感性93%,特异性97%。
- BD MAX对利福平耐药敏感性90%、特异性95%。
- BD MAX对异烟肼耐药敏感性82%、特异性100%。
核心结论
- BD MAX MDR-TB检测对MTB及利福平、异烟肼耐药具有较高敏感性和特异性,可能成为全球快速检测结核和耐多药结核的重要工具。
研究设计与样本
- 前瞻性多中心研究,在南非、乌干达、印度和秘鲁纳入1053例有肺结核症状的门诊成人。
- 对单份原始痰标本进行涂片镜检和BD MAX检测,随后处理痰标本用于培养、表型药敏试验、BD MAX和Xpert MTB/RIF检测。
主要发现
- 在确诊结核患者中,BD MAX检测MTB的敏感性为93%(262/282 [95% CI, 89-95%]),在原始痰培养阴性参与者中特异性为97%(593/610 [96-98%])。
- BD MAX在荧光显微镜涂片阳性样本中的敏感性为100%(175/175 [98-100%]),在涂片阴性样本中为81%(87/107 [73-88%])。
- 在同时接受BD MAX和Xpert检测的参与者中,处理痰标本上BD MAX敏感性为91%(249/274 [87-94%]),Xpert为90%(246/274 [86-93%])。
- 与表型药敏试验相比,BD MAX检测利福平耐药的敏感性和特异性分别为90%(9/10 [60-98%])和95%(211/222 [91-97%])。
- BD MAX检测异烟肼耐药的敏感性和特异性分别为82%(22/27 [63-92%])和100%(205/205 [98-100%])。
临床怎么用
- BD MAX MDR-TB检测可用于疑似肺结核门诊成人痰标本的快速MTB检测及利福平、异烟肼耐药筛查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tuberculosis (TB) control is hindered by absence of rapid tests to identify Mycobacterium tuberculosis (MTB) and detect isoniazid (INH) and rifampin (RIF) resistance. We evaluated the accuracy of the BD MAX multidrug-resistant (MDR)-TB assay (BD MAX) in South Africa, Uganda, India, and Peru. METHODS: Outpatient adults with signs/symptoms of pulmonary TB were prospectively enrolled. Sputum smear microscopy and BD MAX were performed on a single raw sputum, which was then processed for culture and phenotypic drug susceptibility testing (DST), BD MAX, and Xpert MTB/RIF (Xpert). RESULTS: 1053 participants with presumptive TB were enrolled (47% female; 32% with human immunodeficiency virus). In patients with confirmed TB, BD MAX sensitivity was 93% (262/282 [95% CI, 89-95%]); specificity was 97% (593/610 [96-98%]) among participants with negative cultures on raw sputa. BD MAX sensitivity was 100% (175/175 [98-100%]) for smear-positive samples (fluorescence microscopy), and 81% (87/107 [73-88%]) in smear-negative samples. Among participants with both BD MAX and Xpert, sensitivity was 91% (249/274 [87-94%]) for BD MAX and 90% (246/274 [86-93%]) for Xpert on processed sputa. Sensitivity and specificity for RIF resistance compared with phenotypic DST were 90% (9/10 [60-98%]) and 95% (211/222 [91-97%]), respectively. Sensitivity and specificity for detection of INH resistance were 82% (22/27 [63-92%]) and 100% (205/205 [98-100%]), respectively. CONCLUSIONS: The BD MAX MDR-TB assay had high sensitivity and specificity for detection of MTB and RIF and INH drug resistance and may be an important tool for rapid detection of TB and MDR-TB globally.
引用
- Shah M, Paradis S, Betz J, et al. Multicenter Study of the Accuracy of the BD MAX Multidrug-resistant Tuberculosis Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated With Resistance to Rifampin and Isoniazid. Clin Infect Dis. 2020. PMID: 31560049. doi:10.1093/cid/ciz932
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。